Free Trial

Neurogene (NGNE) Insider Trading & Ownership

Neurogene logo
$30.00 -1.28 (-4.08%)
As of 11:52 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Neurogene (NASDAQ:NGNE) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
11.64%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
2
Amount Of
Insider Selling
(Last 12 Months)
$525.62K
Get NGNE Insider Trade Alerts

Want to know when executives and insiders are buying or selling Neurogene stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

NGNE Insider Buying and Selling by Quarter

Neurogene Insider and Congressional Trades History

Transaction DateInsiderBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
5/6/2026Sell9,600$31.25$300,000.00  
3/13/2026Sell4,045$20.81$84,176.45  
3/13/2026Sell6,797$20.81$141,445.57  
(Data available from 1/1/2013 forward)

NGNE Insider Trading Activity - Frequently Asked Questions

The list of insiders at Neurogene includes Christine Mikail Cvijic, Rachel Mcminn, Samsara Biocapital Gp, Llc, and Stuart Cobb. Learn more on insiders at NGNE.

11.64% of Neurogene stock is owned by insiders. Learn more on NGNE's insider holdings.

The following insiders have purchased NGNE shares in the last 24 months: Christine Mikail Cvijic ($491,520.00), Rachel Mcminn ($969,000.00), and Samsara Biocapital Gp, Llc ($1,259,729.10).

Insiders have purchased a total of 120,270 NGNE shares in the last 24 months for a total of $2,720,249.10 bought.

The following insiders have sold NGNE shares in the last 24 months: Christine Mikail Cvijic ($460,423.39), and Stuart Cobb ($244,420.12).

Insiders have sold a total of 31,740 Neurogene shares in the last 24 months for a total of $704,843.51 sold.



This page (NASDAQ:NGNE) was last updated on 5/15/2026 by MarketBeat.com Staff.
From Our Partners